Published in Blood on December 01, 1992
Apoptosis in Polymorphonuclear Cells and Inflammatory Cytokines of Trauma Patients | NCT03319017
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med (1996) 2.39
Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest (2003) 2.14
Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis (1999) 1.75
Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med (1998) 1.75
Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ (2011) 1.64
Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int Immunol (2011) 1.58
Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor. J Exp Med (1999) 1.35
Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest (1996) 1.30
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol (2006) 1.25
Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan. J Immunol (2012) 1.18
Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Res Ther (2007) 1.14
Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res (2009) 1.12
Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun (2003) 1.09
Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis. J Immunol (2012) 1.06
Spontaneous and Fas-induced apoptotic cell death in aged neutrophils. J Clin Immunol (1998) 1.05
p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Br J Pharmacol (2000) 1.02
Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med (1994) 0.98
Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect Immun (2002) 0.97
Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7. Infect Immun (1999) 0.96
Interaction between integrin alpha9beta1 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis. Blood (2005) 0.96
Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem J (1997) 0.94
Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment. Int J Colorectal Dis (2008) 0.93
A functional NADPH oxidase prevents caspase involvement in the clearance of phagocytic neutrophils. Infect Immun (2007) 0.92
Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. Am J Pathol (2001) 0.92
Leptin inhibits neutrophil apoptosis in children via ERK/NF-κB-dependent pathways. PLoS One (2013) 0.89
Francisella tularensis alters human neutrophil gene expression: insights into the molecular basis of delayed neutrophil apoptosis. J Innate Immun (2012) 0.88
Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis. PLoS One (2012) 0.88
Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by the addition of synovial fluid. Ann Rheum Dis (1995) 0.88
Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology (Oxford) (2008) 0.88
HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog (2013) 0.87
Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis. Br J Cancer (1997) 0.87
Novel role of regulatory T cells in limiting early neutrophil responses in skin. Immunology (2010) 0.87
Effects of staphylococcal enterotoxins on human neutrophil functions and apoptosis. Infect Immun (1999) 0.86
Dynamic aspect of reactive oxygen and nitric oxide in oral cavity. J Clin Biochem Nutr (2008) 0.85
Serum and glucocorticoid-regulated kinase 1 regulates neutrophil clearance during inflammation resolution. J Immunol (2014) 0.85
Analysis of the mechanisms involved in the stimulation of neutrophil apoptosis by tumour necrosis factor-alpha. Immunology (2004) 0.85
Expression of caspase-3, p53 and Bcl-2 in generalized aggressive periodontitis. Head Face Med (2006) 0.84
Intraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr-1high polymorphonuclear neutrophils in the murine abdominal cavity. Clin Diagn Lab Immunol (2004) 0.84
Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipoxygenase-activating protein (FLAP) and interleukin-1 beta (IL-1 beta) expression in human neutrophils. Inflammation (1997) 0.84
Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase. Apoptosis (2013) 0.83
Toxoplasma gondii induces granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor secretion by human fibroblasts: implications for neutrophil apoptosis. Infect Immun (2002) 0.83
Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors. Br J Pharmacol (2001) 0.82
Differential regulation of neutrophil chemotaxis to IL-8 and fMLP by GM-CSF: lack of direct effect of oestradiol. Immunology (2006) 0.81
Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol (1995) 0.79
Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells. BMC Microbiol (2014) 0.79
The roles of integrins in function of human neutrophils after their migration through endothelium into interstitial matrix. PLoS One (2015) 0.79
In vitro infection of human nervous cells by two strains of Toxoplasma gondii: a kinetic analysis of immune mediators and parasite multiplication. PLoS One (2014) 0.78
Effects of recombinant GM-CSF and IgA opsonisation on neutrophil phagocytosis of latex beads coated with P6 outer membrane protein from Haemophilus influenzae. Thorax (1993) 0.78
Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members. Inflamm Res (2009) 0.77
TARM1 Is a Novel Leukocyte Receptor Complex-Encoded ITAM Receptor That Costimulates Proinflammatory Cytokine Secretion by Macrophages and Neutrophils. J Immunol (2015) 0.75
HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection. J Acquir Immune Defic Syndr (2011) 0.75
Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis. Mediators Inflamm (1998) 0.75
IL-32γ delays spontaneous apoptosis of human neutrophils through MCL-1, regulated primarily by the p38 MAPK pathway. PLoS One (2014) 0.75
Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells. Clin Exp Immunol (1995) 0.75
Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med (1989) 3.32
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell (1993) 2.73
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med (1991) 2.40
Post-transcriptional regulation of interleukin-6 gene expression in human keratinocytes by ultraviolet B radiation. J Invest Dermatol (1994) 2.09
Acute pancreatitis and normoamylasemia. Not an uncommon combination. Ann Surg (1989) 1.94
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med (1985) 1.87
NEW PENETRATING VEHICLES AND SOLVENTS. Science (1942) 1.86
Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience (2005) 1.84
High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood (1989) 1.64
Normal values for respiratory resistance using forced oscillation in subjects>65 years old. Eur Respir J (2005) 1.61
Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils. J Immunol (1988) 1.51
Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int (2002) 1.47
Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol (2005) 1.45
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells. Blood (1996) 1.40
The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol (1996) 1.38
Community-acquired pneumonia in older patients. J Am Geriatr Soc (1996) 1.37
Retracted Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes. J Clin Invest (1989) 1.37
Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood (1989) 1.33
Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood (1987) 1.31
DEMONSTRATING THE PRESENCE OF SULFONAMIDES IN THE TISSUES. Science (1943) 1.20
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med (2001) 1.19
Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest (1987) 1.18
Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood (1991) 1.17
Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol (1996) 1.16
Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol (1982) 1.14
Human X chromosome markers and Duchenne muscular dystrophy. Nucleic Acids Res (1985) 1.13
Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem (1993) 1.13
Chloroplast lamellar proteins of the plastid mutant en: viridis-1 of Antirrhinum majus having impaired photosystem II. Exp Cell Res (1972) 1.11
Plastid ribosome deficient mutants of Pelargonium zonale. FEBS Lett (1973) 1.10
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology (1997) 1.08
N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood (1990) 1.07
Interleukin-6 in clinical medicine. Ann Hematol (1991) 1.06
CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Leukemia (1995) 1.05
Cellular immunity to the Her-2/neu protooncogene. Adv Cancer Res (2002) 1.05
CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood (1997) 1.05
Interferon-gamma induces expression of the interleukin 2 receptor gene in human monocytes. Eur J Immunol (1987) 1.04
Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today (1997) 1.03
Retracted Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proc Natl Acad Sci U S A (1996) 1.03
Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes. Blood (1989) 1.01
MAPKAP kinase 2 is activated by heat shock and TNF-alpha: in vivo phosphorylation of small heat shock protein results from stimulation of the MAP kinase cascade. J Cell Biochem (1995) 1.01
Reversal of the hip fracture secular trend is related to a decrease in the incidence in institution-dwelling elderly women. Osteoporos Int (2008) 1.00
Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J (1995) 1.00
Retracted Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest (1989) 0.99
Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood (1996) 0.98
In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level. Blood (1987) 0.98
Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro. Int J Cancer (1991) 0.98
CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol (1995) 0.98
Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch Pathol Lab Med (1999) 0.98
Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas. Mod Pathol (1998) 0.98
Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood (1990) 0.97
Immediate causes of death of demented and non-demented elderly. Acta Neurol Scand Suppl (2000) 0.96
Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia (1995) 0.96
Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia (1995) 0.96
Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-chi B and NF-IL6. Eur J Immunol (1992) 0.96
The role of eosinophils in the pathobiology of Hodgkin's disease. Ann Oncol (1997) 0.96
Cause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findings. J Am Geriatr Soc (2001) 0.95
High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease. Lancet (1992) 0.95
Control of tetrahydrobiopterin synthesis in T lymphocytes by synergistic action of interferon-gamma and interleukin-2. J Biol Chem (1990) 0.95
Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res (1992) 0.95
Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood (1986) 0.94
A two-colour chewing gum test for masticatory efficiency: development of different assessment methods. J Oral Rehabil (2007) 0.94
Identification of NF-jun, a novel inducible transcription factor that regulates c-jun gene transcription. EMBO J (1992) 0.94
High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest (1992) 0.93
Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease. Gut (1984) 0.92
Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. Cancer Res (1992) 0.92
Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood (1990) 0.92
Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias. Leuk Lymphoma (1997) 0.91
Retracted Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast. J Clin Invest (1993) 0.91
T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro. J Immunol (1986) 0.91
Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1. J Immunol (1996) 0.90
Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia. J Clin Invest (1986) 0.90
A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. Blood (1992) 0.90
Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol Ther (1996) 0.90
Socioeconomic and living conditions are determinants of hip fracture incidence and age occurrence among community-dwelling elderly. Osteoporos Int (2010) 0.89
Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol (1983) 0.89
The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients. Ann Oncol (1996) 0.89
Mechanisms of p53 alteration in acute leukemias. Leukemia (1994) 0.87
Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia. Cytokines Mol Ther (1996) 0.87
Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol (1990) 0.87
CD30 ligand in lymphoma patients with CD30+ tumors. J Clin Oncol (1997) 0.87
CD30 ligand is expressed on resting normal and malignant human B lymphocytes. Br J Haematol (1996) 0.87
[Studies of the free fatty acids in the surface lipids of healthy human skin]. Arch Klin Exp Dermatol (1968) 0.87
Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa B. Pathobiology (1991) 0.87
Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood (1992) 0.87